China
In a vast and culturally rich nation like China, millions of individuals deserve the opportunity to experience the beauty of sound. The Signia Mobile...
September 26, 2023 | News
"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...
September 26, 2023 | News
Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...
September 26, 2023 | News
Chime Biologics, a leading CDMO that enables its partners' success in biologics, announced a strategic cooperation with Kings Pharm. According to the agre...
September 26, 2023 | News
Chime Biologics, a leading CDMO that enables biologic therapeutics development announced a strategic cooperation agreement with Panolos Bioscience, a South...
September 25, 2023 | News
On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...
September 25, 2023 | News
"Patients with relapsed or refractory PTCL worldwide face limited treatment options and a poor prognosis. We are pleased with the CDE's decision to grant p...
September 22, 2023 | News
Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...
September 22, 2023 | News
This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperi...
September 22, 2023 | News
Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...
September 21, 2023 | News
New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product Do...
September 21, 2023 | News
"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...
September 21, 2023 | News
"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...
September 20, 2023 | News
The facility will host training for more than triple the current number of people per year. The upgraded Fast Trak center will support novel therapy dev...
September 18, 2023 | News
Most Read
Bio Jobs
News
Editor Picks